1. Wood S, Sage JR, Shuman T, et al. Psychostimultants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev, 2014;66(1):193-221
2. Oei JL, Kingsbury A, Dhawan A, et al. Amphetamines, the pregnant woman and her children: a review. J of Perinatol, 2012;32:737-747
3. Main fileCohen JM, Hernandez-Diaz S, Bateman BT, et al. Placental complications associated with psychostimulant use in pregnancy. Obstet Gynecol, 2017;130:1192-1201
4. Bro SP, Kjaersgaard MIS, Parner ET, et al. Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy. Clin Epidemiol, 2015;7:139-147
5. Humphreys C, Garcia-Bournissen F, Ito S, et al. Exposure to attention deficit hyperactivity disorder medications during pregnancy. Can Fam Physician, 2007;53(7):1153-1155
6. Shields N, Muza R, Kosky C, et al. An investigation into the use of stimulant therapy during pregnancy. Sleep disorders, 2012;Article ID 308952, 8 pages, 2012. doi:10.1155/2012/308952
7. Thorpy M, Zhao CG, Dauvilliers Y. Management of narcolepsy during pregnancy. Sleep medicine, 2013;14:367-376
8. Chomchai C, Chomchai S, Kitsommart R. Transfer of Methamphetamine (MA) into Breast Milk and Urine of Postpartum Women who Smoked MA Tablets during Pregnancy: Implications for Initiation of Breastfeeding. J Hum Lact. 2016 May;32(2):333-9. doi: 10.1177/0890334415610080. Epub 2015 Oct 9. PMID: 26452730.
9. ACOG. Methamphetamine abuse in women of reproductive age. Committee opinion. Number 479. 2021. https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Health-Care-for-Underserved-Women/Methamphetamine-Abuse-in-Women-of-Reproductive-Age
10. Smid MC, Metz TD, Gordon AJ. Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clin Obstet Gynecol. 2019;62(1):168-184. doi:10.1097/GRF.0000000000000418